A novel approach to assess gastrointestinal adverse effects of opioids

Mech-Sense, Aalborg University Hospital0 个研究点开始时间: 2013年8月1日最近更新: 2017年10月2日

适应症

试验速览

暂无简介。

•Signed informed consent.
•Able to read and understand Danish.
•Male of Northern European descent (in order to minimize genetic variance in the study population).
•The researcher believes that the subject understands the study details, is compliant and is expected to complete the study.
•Opioid naïve
•Between 20 and 60 years of age.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 70
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 40

•Known allergy towards pharmaceutical compounds similar to those used in the study.
•Participation in other studies within 14 days prior to first visit.
•Expected need of medical/surgical treatment during the course of the study.
•Any disease, which investigator concludes will affect the trial.
•History of substance abuse.
•Family history of substance abuse.
•Daily alcohol consumption
•Daily nicotine consumption (e.g. cigarette smoking, nicotine patch, etc.).
•Need to operate motor vehicle within the study periods.
•Metal implants or pacemaker.
•Piercings.
•Use of prescription medicine and/or herbal medicine.

发起方

Mech-Sense, Aalborg University Hospital